Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1 - PubMed (original) (raw)
. 2006 Jan 12;25(2):278-87.
doi: 10.1038/sj.onc.1209019.
Affiliations
- PMID: 16170359
- DOI: 10.1038/sj.onc.1209019
Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1
A Chen et al. Oncogene. 2006.
Abstract
High expression of epidermal growth factor receptor (EGFR) is found in a variety of solid tumors, including colorectal cancer. EGFR has been identified as a rational target for anticancer therapy. Curcumin, the yellow pigment of turmeric in curry, has received attention as a promising dietary supplement for cancer prevention and treatment. We recently reported that curcumin inhibited the growth of human colon cancer-derived Moser cells by suppressing gene expression of cyclinD1 and EGFR. The aim of the present study was to explore the molecular mechanisms underlying curcumin inhibition of gene expression of EGFR in colon cancer cells. The generality of the inhibitory effect of curcumin on gene expression of EGFR was verified in other human colon cancer-derived cell lines, including Caco-2 and HT-29 cells. Promoter deletion assays and site-directed mutageneses identified a binding site for the transcription factor early growth response-1 (Egr-1) in egfr promoter as a putative curcumin response element in regulating the promoter activity of the gene in Moser cells. Electrophoretic mobility shift assays demonstrated that curcumin significantly reduced the DNA-binding activity of the transcription factor Egr-1 to the curcumin response element. In addition, curcumin reduced the trans-activation activity of Egr-1 by suppressing egr-1 gene expression, which required interruption of the ERK signal pathway and reduction of the level of phosphorylation of Elk-1 and its activity. Taken together, our results demonstrated that curcumin inhibited human colon cancer cell growth by suppressing gene expression of EGFR through reducing the trans-activation activity of Egr-1. These results provided novel insights into the mechanisms of curcumin inhibition of colon cancer cell growth and potential therapeutic strategies for treatment of colon cancer.
Similar articles
- Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.
Chen A, Xu J. Chen A, et al. Am J Physiol Gastrointest Liver Physiol. 2005 Mar;288(3):G447-56. doi: 10.1152/ajpgi.00209.2004. Epub 2004 Oct 14. Am J Physiol Gastrointest Liver Physiol. 2005. PMID: 15486348 - p21 Waf1/Cip1 expression by curcumin in U-87MG human glioma cells: role of early growth response-1 expression.
Choi BH, Kim CG, Bae YS, Lim Y, Lee YH, Shin SY. Choi BH, et al. Cancer Res. 2008 Mar 1;68(5):1369-77. doi: 10.1158/0008-5472.CAN-07-5222. Cancer Res. 2008. PMID: 18316600 - Epidermal growth factor-related peptides as targets for experimental therapy of human colon carcinoma.
Normanno N, De Luca A, Salomon DS, Ciardiello F. Normanno N, et al. Cancer Detect Prev. 1998;22(1):62-7. Cancer Detect Prev. 1998. PMID: 9466051 Review. - Efficacy of ligand-based targeting for the EGF system in cancer.
Yotsumoto F, Sanui A, Fukami T, Shirota K, Horiuchi S, Tsujioka H, Yoshizato T, Kuroki M, Miyamoto S. Yotsumoto F, et al. Anticancer Res. 2009 Nov;29(11):4879-85. Anticancer Res. 2009. PMID: 20032451 Review.
Cited by
- bis-Dehydroxy-Curcumin triggers mitochondrial-associated cell death in human colon cancer cells through ER-stress induced autophagy.
Basile V, Belluti S, Ferrari E, Gozzoli C, Ganassi S, Quaglino D, Saladini M, Imbriano C. Basile V, et al. PLoS One. 2013;8(1):e53664. doi: 10.1371/journal.pone.0053664. Epub 2013 Jan 11. PLoS One. 2013. PMID: 23326480 Free PMC article. - Transcriptomic and proteomic analysis of tumor suppressive effects of GZ17-6.02 against mycosis fungoides.
Bordeaux ZA, Reddy SV, Choi J, Braun G, McKeel J, Lu W, Yossef SM, Ma EZ, West CE, Kwatra SG, Kwatra MM. Bordeaux ZA, et al. Sci Rep. 2024 Jan 23;14(1):1955. doi: 10.1038/s41598-024-52544-z. Sci Rep. 2024. PMID: 38263212 Free PMC article. - Curcumin protects retinal cells from light-and oxidant stress-induced cell death.
Mandal MN, Patlolla JM, Zheng L, Agbaga MP, Tran JT, Wicker L, Kasus-Jacobi A, Elliott MH, Rao CV, Anderson RE. Mandal MN, et al. Free Radic Biol Med. 2009 Mar 1;46(5):672-9. doi: 10.1016/j.freeradbiomed.2008.12.006. Epub 2008 Dec 24. Free Radic Biol Med. 2009. PMID: 19121385 Free PMC article. - A novel TGF-β receptor II mutation (I227T/N236D) promotes aggressive phenotype of oral squamous cell carcinoma via enhanced EGFR signaling.
Son HK, Kim D, Lim Y, Kim J, Park I. Son HK, et al. BMC Cancer. 2020 Nov 27;20(1):1163. doi: 10.1186/s12885-020-07669-5. BMC Cancer. 2020. PMID: 33246423 Free PMC article. - Natural products and colon cancer: current status and future prospects.
Rajamanickam S, Agarwal R. Rajamanickam S, et al. Drug Dev Res. 2008 Nov 1;69(7):460-471. doi: 10.1002/ddr.20276. Drug Dev Res. 2008. PMID: 19884979 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous